View in EDS HTML Full Text PDF Full Text

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.

Saved in:
Bibliographic Details
Title: Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
Authors: Lebwohl MG; Icahn School of Medicine at Mount Sinai, New York, New York., Kircik LH; Icahn School of Medicine at Mount Sinai, New York, New York.; Indiana Medical Center, Indianapolis.; Physicians Skin Care PLLC, Louisville, Kentucky.; Skin Sciences PLLC, Louisville, Kentucky., Moore AY; Arlington Research Center, Arlington, Texas.; Baylor University Medical Center, Dallas, Texas., Stein Gold L; Henry Ford Medical Center, Detroit, Michigan., Draelos ZD; Dermatology Consulting Services, High Point, North Carolina., Gooderham MJ; SkiN Centre for Dermatology, Peterborough, Ontario, Canada.; Probity Medical Research, Peterborough, Ontario, Canada.; Queen's University, Peterborough, Ontario, Canada., Papp KA; Probity Medical Research, Waterloo, Ontario, Canada.; K Papp Clinical Research, Waterloo, Ontario, Canada., Bagel J; Psoriasis Treatment Center of Central New Jersey, East Windsor., Bhatia N; Therapeutics Clinical Research, San Diego, California., Del Rosso JQ; JDR Dermatology Research Center LLC, Las Vegas, Nevada.; Advanced Dermatology and Cosmetic Surgery, Maitland, Florida., Ferris LK; University of Pittsburgh Clinical and Translational Science Institute, Pittsburgh, Pennsylvania., Green LJ; George Washington University School of Medicine, Rockville, Maryland., Hebert AA; UT Health McGovern Medical School, Houston, Texas., Jones T; US Dermatology Partners Bryan, Bryan, Texas., Kempers SE; Minnesota Clinical Study Center, Fridley., Pariser DM; Eastern Virginia Medical School, Norfolk.; Virginia Clinical Research Inc, Norfolk., Yamauchi PS; David Geffen School of Medicine at UCLA, Los Angeles, California.; Dermatology Institute and Skin Care Center Inc, Santa Monica, California., Zirwas M; Dermatologists of the Central States, Bexley, Ohio.; Probity Medical Research, Bexley, Ohio.; Ohio University, Bexley, Ohio., Albrecht L; Enverus Medical Research, Surrey, British Columbia, Canada.; Probity Medical Research, Surrey, British Columbia, Canada., Devani AR; Dermatology Research Institute, Calgary, Alberta, Canada.; Probity Medical Research, Calgary, Alberta, Canada., Lomaga M; DermEdge Research, Mississauga, Ontario, Canada.; Probity Medical Research, Mississauga, Ontario, Canada., Feng A; Arcutis Biotherapeutics Inc, Westlake Village, California., Snyder S; Arcutis Biotherapeutics Inc, Westlake Village, California., Burnett P; Arcutis Biotherapeutics Inc, Westlake Village, California., Higham RC; Arcutis Biotherapeutics Inc, Westlake Village, California., Berk DR; Arcutis Biotherapeutics Inc, Westlake Village, California.
Source: JAMA [JAMA] 2022 Sep 20; Vol. 328 (11), pp. 1073-1084.
Publication Type: Journal Article
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1538-3598
DOI:10.1001/jama.2022.15632